The Irreversible FLT3 Inhibitor FF-10101 Is Active Against a Diversity of FLT3 Inhibitor Resistance MechanismsFF-10101 Overcomes FLT3 TKI Resistance Mechanisms

Overview of attention for article published in Molecular Cancer Therapeutics, April 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 7,483 followers.

RT @MCT_AACR: FF-10101, an inhibitor of FLT3, is active against FLT3 mutations associated with resistance to other FLT3 inhibitors and poss…

01 Jun 2022

Reply Repost Favourite

FF-10101, an inhibitor of FLT3, is active against FLT3 mutations associated with resistance to other FLT3 inhibitors and possesses a resistance profile that may contribute to improved single agent efficacy in patients with FLT3-mutant AML. https://t.co/FU9

31 May 2022

Reply Repost Favourite

RT @RobotRrid: The authors of "Irreversible FLT3 Inhibitor FF-10101 Is Active Aga…" (https://t.co/vIZIpPf2Wz) included RRIDs in their paper…

15 May 2022

Reply Repost Favourite

The authors of "Irreversible FLT3 Inhibitor FF-10101 Is Active Aga…" (https://t.co/vIZIpPf2Wz) included RRIDs in their paper! Thank you for making your #methodsmatter. #OpenScience

15 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.